title: A classification and meta-analysis of community-based directly observed therapy programs for tuberculosis treatment in developing countries.
abstract: In many developing countries, Directly Observed Therapy (DOT) for tuberculosis has been undertaken mainly in the clinic setting. However, clinic-based DOT may create a high patient load in already overburdened health facilities and increase barriers to care by requiring patients to travel to clinic frequently for therapy. Community-based DOT (CBDOT) may overcome some of these problems. This aims of this review are (a) to describe the main features of CBDOT programs, and (b) to compare features and outcomes of CBDOT programs that do and do not offer financial reward for CBDOT providers. Ten major features define CBDOT program structure and function. Programs that paid their CBDOT providers tended to differ from unpaid programs based on all of these features. CBDOT programs in which providers received financial reward had success rates of 85.7 versus 77.6% in programs without financial reward for providers. This difference was not statistically significant. CBDOT programs fall into two major archetypes, which differ in their structure and possibly in their outcomes.
authors.affiliation: Division of Combined Internal Medicine and Pediatrics, Hospital of the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. kangovi@email.chop.edu
authors.forename: Shreya
authors.initials: S
authors.lastname: Kangovi
authors.forename: Joia
authors.initials: J
authors.lastname: Mukherjee
authors.forename: Richard
authors.initials: R
authors.lastname: Bohmer
authors.forename: Garret
authors.initials: G
authors.lastname: Fitzmaurice
mesh_terms: D003153:Community Health Services / Q000191:economics / Q000458:organization & administration*; D003906:Developing Countries; D023801:Directly Observed Therapy / Q000191:economics; D006297:Health Services Accessibility; D006801:Humans; D010816:Physician Incentive Plans; D015397:Program Evaluation; D014376:Tuberculosis / Q000628:therapy*